Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid): FDA 510(k) clearances across all its applicant names
FDA lists 1,103 510(k) clearances, 6 PMA and 4 De Novo decisions across the 34 applicant names Caduvo groups under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid), first 1976, latest 2026. Median 510(k) review time across these names: 68 days. Since 2017 the median was 147 days, against 171 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 11 | 113 |
| 2013 | 14 | 177 |
| 2014 | 16 | 116 |
| 2015 | 8 | 130 |
| 2016 | 10 | 90 |
| 2017 | 15 | 164 |
| 2018 | 9 | 91 |
| 2019 | 16 | 105 |
| 2020 | 8 | 90 |
| 2021 | 2 | 215 |
| 2022 | 7 | 174 |
| 2023 | 22 | 250 |
| 2024 | 24 | 88 |
| 2025 | 17 | 219 |
| 2026 | 20 | 128 |
The 34 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Beckman Instruments, Inc. | 281 | 0 | 0 | 1976–1998 |
| Beckman Coulter, Inc. | 280 | 5 | 1 | 1993–2026 |
| Coulter Electronics, Inc. | 101 | 0 | 0 | 1976–1994 |
| Cepheid | 63 | 0 | 3 | 2006–2026 |
| Hybritech, Inc. | 63 | 0 | 0 | 1981–1997 |
| Coulter Corp. | 51 | 0 | 0 | 1989–2000 |
| Radiometer America, Inc. | 50 | 0 | 0 | 1983–2016 |
| Dade Microscan, Inc. | 40 | 0 | 0 | 1996–2005 |
| Immunotech Corp. | 40 | 0 | 0 | 1980–1995 |
| Radiometer Medical Aps | 28 | 0 | 0 | 2004–2017 |
| Coulter Immunology | 16 | 0 | 0 | 1988–1993 |
| Beckman-Diagnostic Systems Group | 11 | 0 | 0 | 1993–1994 |
| Microscan Div. Baxter Healthcare Corp. | 11 | 0 | 0 | 1987–1987 |
| Hemocue, Inc. | 9 | 0 | 0 | 1991–2004 |
| Beckman Coulter Ireland, Inc. | 7 | 0 | 0 | 2013–2019 |
| Beckman | 6 | 0 | 0 | 1989–1999 |
| Hemocue AB | 6 | 0 | 0 | 2006–2020 |
| Leica Biosystems Newcastle, Ltd. | 6 | 0 | 0 | 2014–2023 |
| Aperio Technologies | 5 | 0 | 0 | 2007–2009 |
| Leica Biosystems Imaging, Inc. | 5 | 0 | 0 | 2014–2026 |
| Radiometer Medicals Aps | 5 | 0 | 0 | 2024–2026 |
| Olympus Diagnostica GmbH | 4 | 0 | 0 | 1998–2000 |
| Iris International, Inc. | 3 | 0 | 0 | 2005–2010 |
| Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd. | 2 | 0 | 0 | 2023–2023 |
| Radiometer Medical A/S | 2 | 0 | 0 | 2000–2000 |
| Beckman Analytical and Biotechnology Development | 1 | 0 | 0 | 1994–1994 |
| Beckman Coulter Biomedical GmbH | 1 | 0 | 0 | 2019–2019 |
| Beckman Coulter Cellular | 1 | 0 | 0 | 2010–2010 |
| Immunotech S.A. | 1 | 0 | 0 | 1993–1993 |
| Immunotech S.R.O. | 1 | 0 | 0 | 2019–2019 |
| Iris International Inc., A Division of Iris Iris I | 1 | 0 | 0 | 2011–2011 |
| Leica Biosystems Richmond | 1 | 0 | 0 | 2014–2014 |
| Radiometer Basel AG | 1 | 0 | 0 | 2007–2007 |
| Leica Biosystems | 0 | 1 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 147 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 171 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| GKZ | Counter, Differential Cell | 86 | 86 |
| JWY | Manual Antimicrobial Susceptibility Test Systems | 38 | 38 |
| CHL | Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph | 31 | 31 |
| JPK | Mixture, Hematology Quality Control | 24 | 24 |
| GKL | Counter, Cell, Automated (Particle Counter) | 22 | 22 |
| LTT | Panels, Test, Susceptibility, Antimicrobial | 22 | 22 |
| JJY | Multi-Analyte Controls, All Kinds (Assayed) | 21 | 21 |
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 20 | 20 |
| JHI | Visual, Pregnancy Hcg, Prescription Use | 17 | 17 |
| JJE | Analyzer, Chemistry (Photometric, Discrete), For Clinical Use | 16 | 16 |
Plus 307 more product codes.
Review panels
- Clinical Chemistry (513)
- Hematology (181)
- Microbiology (172)
- Immunology (118)
- Clinical Toxicology (81)
- Pathology (25)
- Anesthesiology (11)
- General Hospital (2)
- Neurology (2)
- Cardiovascular (1)
- Dental (1)
- Radiology (1)
Most recent Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K262971 | Xpert® Hemorrhagic Fever Panel | Cepheid | QVR | 2026-10-30 | 65 |
| K263333 | Xpert Xpress CoV-2/Flu plus | Cepheid | QOF | 2026-10-22 | 30 |
| K262597 | Access BNP II | Beckman Coulter, Inc. | NBC | 2026-10-20 | 85 |
| K261109 | Access MeMed BV | Beckman Coulter, Inc. | QPS | 2026-10-19 | 199 |
| K263120 | Xpert Xpress CoV-2/Flu plus | Cepheid | QOF | 2026-10-02 | 28 |
| K261336 | Xpert Respiratory Panel | Cepheid | QOF | 2026-09-25 | 155 |
| K262109 | Access NT-proBNP | Beckman Coulter, Inc. | NBC | 2026-09-21 | 90 |
| K261362 | Xpert Hemorrhagic Fever | Cepheid | QVR | 2026-08-07 | 102 |
| K253561 | Aperio iQC DX Software | Leica Biosystems Imaging, Inc. | SIX | 2026-08-07 | 263 |
| K253554 | Aperio GT 450 DX; Aperio GT 180 DX | Leica Biosystems Imaging, Inc. | PSY | 2026-08-07 | 266 |
1,093 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P230015 | PMA | Access HBsAg, Access HBsAg Confirmatory, Access HBsAg Calibrator, Access HBsAg QC | 2025-10-17 |
| DEN240016 | De Novo | Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test | 2024-06-27 |
| DEN160047 | De Novo | Flow Cytometric Test System For Hematopoietic Neoplasms | 2017-06-29 |
| DEN130032 | De Novo | System, Nucleic Acid-Based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen | 2013-07-25 |
| P090026 | PMA | ACCESS HYBRITECH P2PSA ON THE ACCESS IMMUNOASSAY SYSTEMS | 2012-06-14 |
Recalls
787 product recalls in 530 recall events under these names; 129 initiated in the last five years.
21 product recalls in 10 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 12 initiated in the last five years. Most often: Remel Inc (9), Hemo Cue, Inc. (3), Tosoh Bioscience Inc (3).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 16 device studies (0 active or recruiting) with an industry lead sponsor under the 3 sponsor names below. Most recent:
- NCT07491731: Zeus (510K) - 24024 - Stability in Venous and Arterial Blood (Radiometer Medical ApS; Terminated, started 2025-10-07)
- NCT06834880: AQT90 FLEX NTproBNP2 Test Kit - 23004 - Reference Interval Study (Radiometer Medical ApS; Completed, started 2025-01-27)
- NCT06823648: Clinical Precision and In-use Analyte Stability Study for 19 Parameters in Adult Arterial Whole Blood for PICO70 and SafePICO (Radiometer Medical ApS; Completed, started 2024-06-18)
- NCT06702267: Clinical Precision and In-use Analyte Stability Study for Four (4) Parameters in Neonate Arterial Blood for PICO70 and SafePICO (Radiometer Medical ApS; Completed, started 2023-12-12)
- NCT07051278: ABL90 FLEX PLUS Method Comparison Neonatal Capillary (Radiometer Medical ApS; Completed, started 2023-11-10)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Radiometer Medical ApS | 9 |
| Beckman Coulter, Inc. | 4 |
| Cepheid | 3 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
Parent company SEC filings
DANAHER CORP /DE/ (DHR): EDGAR filings, CIK 313616. The parent's SEC registrant is entered by hand for this group, not matched by name.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Radiometer (2004), Leica (2005), HemoCue (2013 via Radiometer), Beckman Coulter (2011; Beckman had merged with Coulter 1997 and bought Hybritech and Immunotech), IRIS International (2012), Cepheid (2016), MicroScan (from Siemens, 2018) and Olympus's lab-diagnostics business (2009). Includes filings made before each acquisition. Left out: Leica Microsystems (microscopy), dental businesses (spun off as Envista 2019).
Sources
- https://en.wikipedia.org/wiki/Danaher_Corporation
- https://en.wikipedia.org/wiki/Beckman_Coulter
- https://en.wikipedia.org/wiki/Cepheid_(company)
- https://en.wikipedia.org/wiki/Radiometer_(company)
Frequently asked questions
How many FDA 510(k) clearances are listed across Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid)'s applicant names?
FDA lists 1,103 510(k) clearances, 6 PMA and 4 De Novo decisions across the 34 applicant names Caduvo groups under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid), first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) file under?
The names with the most 510(k) clearances in this group are Beckman Instruments, Inc. (281); Beckman Coulter, Inc. (280); Coulter Electronics, Inc. (101); Cepheid (63); Hybritech, Inc. (63). The full list of 34 names is on this page.
How long does FDA take to clear Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 68 days. Since 2017 the median was 147 days, against 171 days for all cleared 510(k)s in the same product codes.
Does the Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) sponsor?
ClinicalTrials.gov lists 16 device studies (0 active or recruiting) with an industry lead sponsor under 3 sponsor names Caduvo groups under Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid). ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 1,103 Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid) clearances with predicates and recalls
- Run predicate analysis for product code GKZ, Danaher (Beckman Coulter, Leica Biosystems, Radiometer, Cepheid)'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup